Newsroom Pro

Fyfe-chaired medicinal cannabis firm gets $6 mln investment

 Pure Cann New Zealand, which counts former Air New Zealand boss Rob Fyfe as its executive chair, has secured $6 million from Australia's Cann Group for a 20 percent stake in the local medicinal cannabis company.

The investment will be made over stages with the initial 10 percent to be completed on or before Aug. 30 and a further 10 percent when New Zealand regulations come into force and Pure Cann's

TO READ THE FULL STORY ON NEWSROOM PRO

SUBSCRIBE TO PRO

Subscribe now to start a free trial of Newsroom Pro for 28 days.

View our subscription options

Comments

Newsroom does not allow comments directly on this website. We invite all readers who wish to discuss a story or leave a comment to visit us on Twitter or Facebook. We also welcome your news tips and feedback via email: contact@newsroom.co.nz. Thank you.

PARTNERS